Conspicuously, plasma from all AD subjects (independent of APOE ε4 status) has a greater effect on promoting the Aβ42-α7nAChR association, and lymphocytes of AD subjects have more abundant Aβ42-α7-like nAChR complexes. This evidence concerns the gene CHRNA7 and Alzheimer disease.